Company intelligence / Profile preview

Firm Ferment

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Ferment is a company creation studio focused on building new businesses that leverage synthetic biology and the Ginkgo Bioworks platform. Launched by Ginkgo Bioworks, the firm partners with entrepreneurs and industry leaders to identify market opportunities where biological engineering can provide a competitive advantage. Ferment provides its portfolio companies with access to Ginkgo's foundry and codebase, as well as strategic support and capital. The studio's focus spans various sectors, including agriculture, industrial biotechnology, and healthcare, aiming to accelerate the commercialization of synthetic biology products.

Modalities: Microbial therapyCell therapySmall moleculeProtein
Industry: Investors

Partnerships

Ginkgo BioworksBayerViking Global Investors

Beyond the preview

Go deeper on Firm Ferment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Firm Ferment.

Explore the full profile